These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 34063377)

  • 1. Association of Zinc Deficiency with Development of CVD Events in Patients with CKD.
    Nakatani S; Mori K; Shoji T; Emoto M
    Nutrients; 2021 May; 13(5):. PubMed ID: 34063377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum calcification propensity predicts all-cause mortality in predialysis CKD.
    Smith ER; Ford ML; Tomlinson LA; Bodenham E; McMahon LP; Farese S; Rajkumar C; Holt SG; Pasch A
    J Am Soc Nephrol; 2014 Feb; 25(2):339-48. PubMed ID: 24179171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-
    Voelkl J; Tuffaha R; Luong TTD; Zickler D; Masyout J; Feger M; Verheyen N; Blaschke F; Kuro-O M; Tomaschitz A; Pilz S; Pasch A; Eckardt KU; Scherberich JE; Lang F; Pieske B; Alesutan I
    J Am Soc Nephrol; 2018 Jun; 29(6):1636-1648. PubMed ID: 29654213
    [No Abstract]   [Full Text] [Related]  

  • 4. Arterial location-specific calcification at the carotid artery and aortic arch for chronic kidney disease, diabetes mellitus, hypertension, and dyslipidemia.
    Yamada S; Oshima M; Watanabe Y; Miyake H
    Calcif Tissue Int; 2014 Sep; 95(3):267-74. PubMed ID: 25017195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic kidney disease-a cardiovascular high-risk constellation].
    Speer T; Schunk SJ; Fliser D
    Internist (Berl); 2020 Apr; 61(4):340-348. PubMed ID: 31578597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial.
    Lioufas NM; Pedagogos E; Hawley CM; Pascoe EM; Elder GJ; Badve SV; Valks A; Toussaint ND;
    Am J Nephrol; 2020; 51(3):201-215. PubMed ID: 32023606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particles.
    Chen W; Anokhina V; Dieudonne G; Abramowitz MK; Kashyap R; Yan C; Wu TT; de Mesy Bentley KL; Miller BL; Bushinsky DA
    Nephrol Dial Transplant; 2019 Jun; 34(6):992-1000. PubMed ID: 29788425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of zinc in chronic kidney disease].
    Fukushima T
    Nihon Rinsho; 2016 Jul; 74(7):1138-43. PubMed ID: 27455803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels.
    Gondouin B; Jourde-Chiche N; Sallee M; Dou L; Cerini C; Loundou A; Morange S; Berland Y; Burtey S; Brunet P; Guieu R; Dussol B
    Nephron; 2015; 131(3):167-74. PubMed ID: 26426087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum calcification propensity is associated with renal tissue oxygenation and resistive index in patients with arterial hypertension or chronic kidney disease.
    Pruijm M; Lu Y; Megdiche F; Piskunowicz M; Milani B; Stuber M; Bachtler M; Vogt B; Burnier M; Pasch A
    J Hypertens; 2017 Oct; 35(10):2044-2052. PubMed ID: 28562422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review.
    Pluquet M; Kamel S; Choukroun G; Liabeuf S; Laville SM
    Toxins (Basel); 2022 Sep; 14(9):. PubMed ID: 36136575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Klotho, Cardiovascular Events, and Mortality in Nondiabetic Chronic Kidney Disease.
    Yang K; Yang J; Bi X; Yu Z; Xiao T; Huang Y; Liu Y; Xiong J; Zhao J
    Cardiorenal Med; 2020; 10(3):175-187. PubMed ID: 32294646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of dyslipidemia and oxidative stress on vasoactive mediators in patients with renal dysfunction.
    Jabarpour M; Rashtchizadeh N; Argani H; Ghorbanihaghjo A; Ranjbarzadhag M; Sanajou D; Panah F; Alirezaei A
    Int Urol Nephrol; 2019 Dec; 51(12):2235-2242. PubMed ID: 31641998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery calcification in patients with diabetes mellitus and advanced chronic kidney disease.
    Cano-Megías M; Bouarich H; Guisado-Vasco P; Pérez Fernández M; de Arriba-de la Fuente G; Álvarez-Sanz C; Rodríguez-Puyol D
    Endocrinol Diabetes Nutr (Engl Ed); 2019 May; 66(5):297-304. PubMed ID: 30509882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemia, malnutrition, inflammation, cardiovascular disease and mortality in chronic kidney disease.
    Peev V; Nayer A; Contreras G
    Curr Opin Lipidol; 2014 Feb; 25(1):54-60. PubMed ID: 24345987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Serum Zinc and Calcification Propensity (T
    Nakatani S; Mori K; Sonoda M; Nishide K; Uedono H; Tsuda A; Emoto M; Shoji T
    Biomedicines; 2020 Sep; 8(9):. PubMed ID: 32916995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Bundy JD; Cai X; Scialla JJ; Dobre MA; Chen J; Hsu CY; Leonard MB; Go AS; Rao PS; Lash JP; Townsend RR; Feldman HI; de Boer IH; Block GA; Wolf M; Smith ER; Pasch A; Isakova T;
    Am J Kidney Dis; 2019 Jun; 73(6):806-814. PubMed ID: 30935773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
    Bover J; Ureña-Torres P; Lloret MJ; Ruiz-García C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J
    Expert Opin Pharmacother; 2016 Jun; 17(9):1247-58. PubMed ID: 27156993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart and kidney disease: a cardiovascular high-risk constellation.
    Schunk SJ; Speer T; Fliser D
    Herz; 2021 Jun; 46(3):206-211. PubMed ID: 33377985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abdominal aorta and pelvic artery calcifications on plain radiographs may predict mortality in chronic kidney disease, hemodialysis and renal transplantation.
    Disthabanchong S; Vipattawat K; Phakdeekitcharoen B; Kitiyakara C; Sumethkul V
    Int Urol Nephrol; 2018 Feb; 50(2):355-364. PubMed ID: 29236239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.